Primary Prevention of Stroke in Children With Sickle Cell Disease in Sub-Saharan Africa II

Trial Profile

Primary Prevention of Stroke in Children With Sickle Cell Disease in Sub-Saharan Africa II

Recruiting
Phase of Trial: Phase III

Latest Information Update: 24 Mar 2017

At a glance

  • Drugs Hydroxycarbamide (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Acronyms SPRING
  • Most Recent Events

    • 21 Jul 2016 Planned number of patients changed from 220 to 440.
    • 21 Jul 2016 Status changed from not yet recruiting to recruiting.
    • 02 Dec 2015 Planned initiation date changed from 1 Sep 2015 to 1 Jan 2016, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top